Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Non-cash Items: 2010-2017

  • Corcept Therapeutics' Non-cash Items rose 15.04% to $12.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $12.0 million, marking a year-over-year increase of 15.04%. This contributed to the annual value of $263.1 million for FY2017, which is 310.36% up from last year.
  • Latest data reveals that Corcept Therapeutics reported Non-cash Items of $12.0 million as of Q4 2017, which was up 15.04% from $10.5 million recorded in Q4 2016.
  • Corcept Therapeutics' 5-year Non-cash Items high stood at $12.0 million for Q4 2017, and its period low was $10.5 million during Q4 2016.
  • Its 2-year average for Non-cash Items is $11.3 million, with a median of $11.3 million in 2016.
  • Data for Corcept Therapeutics' Non-cash Items shows a peak YoY rose of 15.04% (in 2017) over the last 5 years.
  • Corcept Therapeutics' Non-cash Items (Quarterly) stood at $10.5 million in 2016, then climbed by 15.04% to $12.0 million in 2017.
  • Its Non-cash Items was $12.0 million in Q4 2017, compared to $10.5 million in Q4 2016 and $8.5 million in Q4 2010.